Legalizing Marijuana in Canada — A Double-Edged Sword: A Response to Recent Commentaries

legalizing marijuana in canada — a double-edged sword: a response to recent commentaries

0

Legalizing Marijuana in Canada — A Double-Edged Sword: A Response to Recent Commentaries

*Correspondence to: Mohammad Hajizadeh, Email: [email protected] Copyright: © 2017 The Author(s); Published by Kerman University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the origi...

Politics Matters: A Response to Recent Commentaries

The Pill Really Can Be Mightier Than the Sword: A Response to Recent Commentaries

We appreciate the four commentaries that add new material and fresh perspectives to our article “The pill is mightier than the sword.” In emphasizing the role of voluntary family planning and girls’ education as achievable strategies with a potential to make the world a more peaceable place, we did not mean to oversimplify or disregard the intrinsic complexity of human conflict. On the whole, t...

A Double-Edged Sword?

The enormous benefits of inhibition of ACE demonstrate that manipulation of the metabolism of peptide hormones is a valuable therapeutic strategy for cardiovascular disease. Recent attempts to expand these benefits have combined ACE inhibition with inhibition of other peptidases such as neutral endopeptidase (NEP) in a single molecule, a strategy known as vasopeptidase inhibition. NEP metaboliz...

A Double-Edged Sword

Ischemic heart disease remains a leading cause of morbidity and mortality. The survival after acute ischemic events has improved substantially in recent years, but new syndromes have emerged. Cardiac remodeling following a large myocardial infarction, with dilatation of the left ventricle, has deleterious hemodynamic consequences and is a major cause of chronic heart failure.1 The increased inc...